Cott (TSE:PRM) Raised to “Strong-Buy” at BMO Capital Markets

BMO Capital Markets upgraded shares of Cott (TSE:PRM) to a strong-buy rating in a report issued on Monday morning,Zacks.com reports.

Several other analysts have also recently issued reports on PRM. Raymond James cut Cott from a “moderate buy” rating to a “hold” rating in a report on Wednesday, October 2nd. William Blair upgraded shares of Cott to a “strong-buy” rating in a research report on Thursday, October 24th.

Cott Trading Up 0.7 %

Shares of PRM stock opened at C$13.39 on Monday. Cott has a 12-month low of C$12.95 and a 12-month high of C$14.97. The stock has a 50-day moving average price of C$13.25.

Cott Dividend Announcement

The business also recently declared a None dividend, which was paid on Thursday, November 21st. Investors of record on Tuesday, November 5th were given a $1.109 dividend. The ex-dividend date of this dividend was Tuesday, November 5th.

About Cott

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.